Skip to content
Human Health

Flagship CEO Chat: Mahesh Karande, Omega Therapeutics

Mahesh Karande, President and CEO of Omega Therapeutics, describes the company’s systematic approach to using mRNA therapeutics as epigenetic medicines, with the ability to control abnormal gene expression in a range of diseases, as well as why so many “Omegans” have stayed with the company as it has grown. More from Flagship @ JPM2023 here.

If you see an error in this story, contact us.

More from: Human Health